Loading...
XSHE
300246
Market cap311mUSD
Dec 05, Last price  
8.42CNY
1D
1.45%
1Q
-4.75%
Jan 2017
-62.12%
IPO
14.71%
Name

Guangdong Biolight Meditech Co Ltd

Chart & Performance

D1W1MN
XSHE:300246 chart
P/E
P/S
2.08
EPS
Div Yield, %
Shrs. gr., 5y
3.68%
Rev. gr., 5y
5.13%
Revenues
1.06b
-11.18%
86,314,031103,443,225143,634,086158,103,676182,285,238234,831,957288,993,464380,505,475594,314,416711,472,879813,385,394825,961,0941,396,013,5721,091,018,4341,183,699,6801,194,001,1291,060,481,198
Net income
-71m
L+9.60%
10,564,21920,405,07332,991,28933,775,32036,505,94028,923,72133,801,50223,918,99267,143,47457,547,28564,193,40164,712,757346,147,54863,792,59522,132,612-65,185,130-71,441,315
CFO
-9m
L
12,675,16517,193,52540,087,80829,057,31240,515,47427,320,09742,310,64028,397,76050,805,21472,306,09181,207,34781,425,906455,780,88480,613,715140,721,997129,047,347-8,636,420
Dividend
May 25, 20230.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.
IPO date
Jul 19, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT